Moreover, the administration of pVAX-IL-24 alone elicited considerable non-specific protective immunity against T. gondii, suggesting its potential as an immunotherapeutic modulator for T. gondii vaccines and even a possibility that IL-24 stimulants could be used as potential adjuvant drugs to prevent parasite infection or their potential role in combination with the described DNA vaccines, depending on its critical role in the anti-tumor drugs [46,47]. Here, IL24 is linked to neoplasm.